Clinical Trial 53225

Chattanooga, TN 37421


Moderate To Severe Ulcerative Colitis

The primary objective of this study is to evaluate the long-term safety and tolerability of an investigational medication in participants with moderate to severe ulcerative colitis (UC).

To qualify, you must:

  • Be 18-80 years old
  • Diagnosis of UC established at least 3 months prior to enrollment by clinical and endoscopic evidence

Qualified Participants May Receive:

Compensation for time and travel

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.